DrugWise Discovery ApS — Credit Rating and Financial Key Figures
CVR number: 43888862
Marielystvej 4 A, 2000 Frederiksberg
Income statement (kDKK)
2023 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 286.84 |
| EBIT | 286.84 |
| Other financial expenses | -0.90 |
| Pre-tax profit | 285.94 |
| Income taxes | -62.90 |
| Net earnings | 223.04 |
Assets (kDKK)
2023 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 31.25 |
| Short term receivables total | 31.25 |
| Cash and bank deposits | 330.69 |
| Cash and cash equivalents | 330.69 |
| Balance sheet total (assets) | 361.94 |
Equity and liabilities (kDKK)
2023 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | 223.04 |
| Shareholders equity total | 263.04 |
| Non-current liabilities total | |
| Current owed to participating | 3.25 |
| Short-term deferred tax liabilities | 62.90 |
| Other non-interest bearing current liabilities | 32.75 |
| Current liabilities total | 98.90 |
| Balance sheet total (liabilities) | 361.94 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.